KLRS
Financials
- Market Capitalization 114.68 M
- Employee 20
- Founded 2019
- CEO N/A
- Website www.kalaristx.com
- Headquarter Delaware, United States
- FIGI BBG00P80SH34
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3920 |  ALDX Aldeyra Therapeutics, Inc. - Common Stock | 1.92 USD | -0.52% | -10.28% | +8.47% | -63.08% | 115.82 M USD | ||
| 3922 |  CUE Cue Biopharma, Inc. - Common Stock | 28.49 USD | -8.92% | -19.36% | +19.01% | +3251.76% | 115.26 M USD | ||
| 3934 |  COYA Coya Therapeutics, Inc. - Common Stock | 4.84 USD | -0.62% | -9.87% | +2.76% | -16.41% | 113.53 M USD | ||
| 3953 |  ONCY Oncolytics Biotech Inc. - Common Stock | 0.90 USD | -1.10% | +12.50% | -6.25% | -30.23% | 107.42 M USD |
Frequently asked questions about Kalaris Therapeutics, Inc. - Common Stock
What is the Kalaris Therapeutics, Inc. - Common Stock stock price today?
The current price of Kalaris Therapeutics, Inc. - Common Stock (KLRS) is 4.82. Over the past 24 hours, the stock has changed by +5.93%. Follow the KLRS chart for real-time price dynamics.
What is the stock ticker of Kalaris Therapeutics, Inc. - Common Stock?
Kalaris Therapeutics, Inc. - Common Stock trades under the ticker KLRS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Kalaris Therapeutics, Inc. - Common Stock stock going up?
KLRS has changed by +1.90% over the last week, +5.93% over the last month, and -52.88% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Kalaris Therapeutics, Inc. - Common Stock net income for the last quarter?
Kalaris Therapeutics, Inc. - Common Stock reported net income of -10.86 M for the last quarter. The previous quarter showed -10 M, which means net income changed by -8.58%.
How many employees does Kalaris Therapeutics, Inc. - Common Stock have?
As of the latest available data, Kalaris Therapeutics, Inc. - Common Stock has 20 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Kalaris Therapeutics, Inc. - Common Stock stock?
You can buy Kalaris Therapeutics, Inc. - Common Stock (KLRS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Kalaris Therapeutics, Inc. - Common Stock stock?
Investing in Kalaris Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KLRS chart and related analysis on metatrader.com as part of your research.